Delivery Order SPE2DX15D3012-SPE2DX24F8PR2
Award Date
6/4/24
Potential Completion Date
6/26/24
Potential Value
$2.2K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $13,184.46, is for the supply of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $21,974.10 firm-fixed-price delivery order is for the supply of LEQVIO 284 MG/1.5 ML syringes. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities to...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Department of Defense (DoD) Medical Supply Chain (VPDLATSMED-A). The contract is for $10,987.05 and provides the DoD with the pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. The award has an ultimate completion date of July 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,197.41 and a completion date of July 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is valued at $21,974.10 and runs through February 23, 2024. It involves the delivery of the specialty pharmaceutical product LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML to support military treatment programs and facilities. Amerisourcebergen Drug Corp...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a Delivery Order contract valued at $6,592.23 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of the prescription drug LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a period of performance through July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,197.41 firm fixed-price delivery order is for the supply of 4564977632 - LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a performance period ending on July 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves...
This is a $13,953.30 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides 4567377135 LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a period of performance through March 18, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,255.50, is a delivery order for the medical product "LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML". The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the procurement of Leqvio 284 mg/1.5 ml syringes. The Firm Fixed Price contract, valued at $21,974.10, has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through...